Charlotte's Web Holdings, Inc.

Equities

CWEB

CA16106R1091

Pharmaceuticals

Delayed Toronto S.E. 02:00:04 2024-03-28 pm EDT 5-day change 1st Jan Change
0.265 CAD -1.85% Intraday chart for Charlotte's Web Holdings, Inc. +10.42% -1.85%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Charlotte's Web Holdings, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Charlotte's Web Holdings Narrows Q4 Loss, Revenue Falls MT
Charlotte's Web Brief: Q4 Net loss per common share, basic and diluted US$(0.06) MT
Charlotte's Web Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Charlotte's Web Holdings, Inc. Launches its Latest Innovation, "Stay Asleep" CBN Gummies CI
Charlotte's Web Holdings, Inc. Announces Changes to Its Board of Directors CI
Charlotte's Web Says DeFloria LLC Starts Phase 1 Clinical Program For Full Spectrum Hemp Botanical Drug MT
Transcript : Charlotte's Web Holdings, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Charlotte's Web Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Charlotte's Web Holdings, Inc. Appoints Angela Mcelwee to Its Board of Directors CI
Charlotte's Web Joins "Historic" Alliance One Hemp to Support FDA Regulation MT
Charlotte's Web Holdings, Inc. Appoints William Morachnick as Non-Independent Director CI
Charlotte's Web Holdings, Inc. Announces Chief Executive Officer Changes CI
Charlotte's Web Appoints Bill Morachnick as Chief Executive Officer MT
Charlotte's Web Brief: Appointing Bill Morachnick as Chief Executive Officer MT
Charlotte's Web Holdings, Inc. Appoints Sarah Cambridge as Chief Accounting Officer CI
Transcript : Charlotte's Web Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023
Charlotte's Web Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Charlotte's Web Holdings, Inc. Expands ReCreateTM Brand Further Cementing the Intersection of CBD in Sports, Paving the Way for Industry Transformation CI
Declaration of Voting Results by Charlotte's Web Holdings CI
Jesse and Joel Stanley Provides Information to the Shareholders CI
Charlotte's Web Comments on Letter from Joel and Jesse Stanley CI
Charlotte's Web Brief: Jesse and Joel Stanley, the "Concerned Shareholders"), co-founders of Charlotte's Web, Say Board Refuses to Engage With Them MT
Charlotte's Web Co-Founders Jesse and Joel Stanley Seek Changes to the Board to "Enhance Shareholder Value" MT
Jesse and Joel Stanley Provides Information to Shareholders of Charlotte's Web Holdings Inc CI
Chart Charlotte's Web Holdings, Inc.
More charts
Charlotte's Web Holdings, Inc. (Charlotte’s) is engaged in providing hemp extract wellness products under a family of brands which includes Charlotte’s Web, CBD Medic, CBD Clinic, and Harmony Hemp. Charlotte’s Web branded products start with its hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include full spectrum hemp extract oil tinctures (liquid products), gummies (sleep, calm, immunity, exercise recovery, daily wellness, THC-free), capsules, topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web products are distributed to retail outlets and health care practitioners, as well as online through the Company’s Website at www.Charlottesweb.com.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.1987 USD
Average target price
0.554 USD
Spread / Average Target
+178.84%
Consensus